Literature DB >> 10515870

Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin.

D L Beckman1, L L Lin, M E Quinones, G D Longmore.   

Abstract

Erythropoietin (EPO) is required for the survival and expansion of red blood cell progenitor cells and supports continued differentiation of these committed progenitors to mature red blood cells. After binding to its cognate receptor, EPO promotes receptor homodimerization, activation of receptor-associated JAK2, subsequent receptor tyrosine phosphorylation, and transduction of signal. EPO is also internalized and degraded in lysosomes. The contribution of EPO-induced receptor internalization to modulation of EPO signals has not been determined. To examine this question, we generated a panel of hematopoietic cell lines containing progressively truncated isoforms of the erythropoietin receptor (EPO-R) and determined the rate and extent of EPO internalization and receptor downregulation. We demonstrated that a membrane-proximal domain of the cytoplasmic tail of the EPO-R was the minimal region required for EPO-induced receptor internalization. This cytoplasmic domain is also the minimal domain required for activation of JAK2, a cytosolic tyrosine kinase essential for the function of the EPO-R. However, neither EPO activation of cytosolic JAK2 tyrosine kinase activity nor tyrosine phosphorylation of the EPO-R cytoplasmic tail was required for EPO-induced receptor downregulation. Both functional and nonfunctional cell surface receptor isoforms were internalized equally. These results suggest that, for downregulation of cell surface ligand occupied EPO-R and possibly for signaling receptors of the cytokine receptor superfamily in general, internalization of cell surface ligand occupied receptors may follow a pathway distinct from signaling receptors of the receptor tyrosine kinase (RTK) family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515870

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling.

Authors:  C Li; C Shi; J Kim; Y Chen; S Ni; L Jiang; C Zheng; D Li; J Hou; R S Taichman; H Sun
Journal:  J Dent Res       Date:  2015-01-13       Impact factor: 6.116

2.  Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.

Authors:  Iva Afrikanova; Ellen Yeh; David Bartos; Stephanie S Watowich; Gregory D Longmore
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

3.  Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells.

Authors:  Juu-Chin Lu; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

4.  Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.

Authors:  Kevin J Freise; John A Widness; Jeffrey L Segar; Robert L Schmidt; Peter Veng-Pedersen
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

Review 5.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

6.  An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.

Authors:  Orly Ravid; Imad Shams; Nathalie Ben Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

7.  TYK2 activity promotes ligand-induced IFNAR1 proteolysis.

Authors:  Zrinka Marijanovic; Josiane Ragimbeau; K G Suresh Kumar; Serge Y Fuchs; Sandra Pellegrini
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

8.  Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.

Authors:  Rita Sulahian; Ondine Cleaver; Lily Jun-shen Huang
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

9.  Correlated receptor transport processes buffer single-cell heterogeneity.

Authors:  Stefan M Kallenberger; Anne L Unger; Stefan Legewie; Konstantinos Lymperopoulos; Ursula Klingmüller; Roland Eils; Dirk-Peter Herten
Journal:  PLoS Comput Biol       Date:  2017-09-25       Impact factor: 4.475

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.